04 August 2021>: Animal Study
Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway
Jun Ding 1ABCDEFG** , Chuang Qi 2BCDEF* , Jinmao Li 1BCDF , Chuying Huang 2BCD , Jiayao Zhang 1BCF , Yong Zhang 1BC , Yi Li 1BCF , Bin Fan 1CFDOI: 10.12659/MSM.929255
Med Sci Monit 2021; 27:e929255
Figure 1 Images of liver tissues from hepatocellular carcinoma rat model and model that received 3 mg/kg se-methylselenocysteine (MSC) treatment at 2, 4, 8, and 10 weeks after treatment. The white arrows represent the tumor tissues.